Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan

Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan by Petar Savic (Prem Sangeet)

As a Venture Scientist and General Partner at Supreme Factory, my work has always been at the intersection of academic rigor and scalable innovation. My mission is simple: to find the protocols, the science, and the technologies that don’t just add years to our lives, but life to our years.

That mission is taking me back to Singapore this February. Often cited as a “Blue Zone 3.0,” Singapore isn’t just a place where people live longer – it’s a living laboratory where policy, environment, and cutting-edge medicine converge. This month, I am honored to contribute to that ecosystem as a panelist and a judge/mentor at the Unlock Healthy Longevity Conference 2026.


Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan

The Shift: From Sick-Care to Precision Geromedicine

We are currently witnessing a massive paradigm shift. For decades, medicine has focused on treating age-related diseases after they appear. The NUS Academy for Healthy Longevity at the Yong Loo Lin School of Medicine is flipping the script.

Led by world-renowned experts, the Academy is pioneering Precision Geromedicine – a field dedicated to targeting the biological process of aging itself. Their mission aligns perfectly with our mandate at Supreme Factory: translating groundbreaking clinical trials into real-world practice and scalable ventures so that health and vitality are attainable for as long as possible.


Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan

Mentoring the Next Frontier of Longevity Startups

One of the most exciting parts of my role at this conference is serving as a judge and mentor for the Longevity Startup Competition. In my experience building venture studios, the “valley of death” between a lab discovery and a consumer product is where most innovation fails. My goal as a judge is to help these startups bridge that gap, ensuring that the most promising health innovations actually reach the people who need them.

I am particularly looking forward to reviewing the diverse batch of finalists pitching this year, including:

  • ieumBio Co Ltd: Validating longevity interventions using a proprietary vertebrate-based killifish platform.

  • Myomar Molecular: Developing non-invasive, urine-based muscle health monitoring tests to combat sarcopenia.

  • LongevAI: Building a clinical operating system (LongevOS) to streamline longevity medicine workflows.

  • MenSC Labs: Leveraging menstrual blood as a scalable and affordable source of stem cells for regenerative medicine.

  • AVEA: A Swiss-based startup optimizing healthspan through scientifically backed dietary supplements.

  • Lateral Pharma: Developing a first-in-class drug platform targeting biological pathways for cell health and survival.

  • Lambert Therapeutics: Advancing cannabinoid-based and hemp-derived molecules with lifespan-extending properties.

  • Don’t Age Project: Vietnam’s first Zalo-native health system connecting lifestyle inputs to biological outputs.

  • KODO: A Singapore-based longevity platform integrating community, nutraceuticals, and habit-tracking technology.

We will also be hearing flash pitches from The Century Kit, SoundEye, AlTreat, Anti-aging Sciences Propulsion Labs, Cenz, and Sugbee.


Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan

The Judging Panel

I am honored to evaluate these groundbreaking innovations alongside a distinguished panel of leaders from the investment, government, and biotech sectors. It is a privilege to work with:

  • Petar Savic: General Partner, Supreme Factory (Venture Studio Fund)

  • Clarice Chen: Director, Healthcare & Biomedical at Enterprise Singapore (EnterpriseSG)

  • John Zhang: Senior Commercial Director at NovogeneAIT

Together, we aim to provide the mentorship and strategic feedback necessary to take these “bench-to-bedside” innovations to a global market.


Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan

A Convergence of Global Minds

I’m looking forward to engaging with the 20+ world-class speakers – titans of the industry like Andrea Maier, Brian Kennedy, and Nir Barzilai – who are defining the future of supplements and drug repurposing.

If you are a researcher, a clinician, an investor, a founder, or an innovator, I invite you to join us. This is more than a scientific meeting; it is a global networking event designed to build the collaborations that will redefine human healthspan.

  • Dates: 26th–27th February 2026

  • Venue: Shaw Foundation Alumni House, National University of Singapore

  • Full Agenda & Registration: https://geromedicine.sg/


Unlocking Healthy Longevity in Singapore: Investing in the Future of Healthspan

Join the Evolution of Healthspan

This journey to Singapore is just one piece of the puzzle. As I continue my work in Venture Science ecosystems with the Supreme Factory studio fund, building community at the LGVT Club, and leading research at State On Demand, I’ll be sharing deep dives into the specific markets, startups, funding, and protocols that are actually moving the needle.

If you want to stay at the cutting edge of how we are translating lab science into ventures and daily human optimization, follow Petar Savic (Prem Sangeet) and subscribe to the Supreme Factory newsletter for real-time updates from the front lines of the longevity revolution.